These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29692262)

  • 1. Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino S; Privitera S; Favilla V; Cantiello F; Manno S; Cicione A; Damiano R; Russo GI; Morgia G
    Anticancer Agents Med Chem; 2018; 18(7):958-963. PubMed ID: 29692262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
    Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance for prostate cancer.
    Romero-Otero J; García-Gómez B; Duarte-Ojeda JM; Rodríguez-Antolín A; Vilaseca A; Carlsson SV; Touijer KA
    Int J Urol; 2016 Mar; 23(3):211-8. PubMed ID: 26621054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest Evidence on the Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Insignificant Prostate Cancer: A Systematic Review.
    Cantiello F; Manno S; Russo GI; Cimino S; Privitera S; Morgia G; Cicione A; Damiano R
    Anticancer Agents Med Chem; 2018; 18(7):925-930. PubMed ID: 29303080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance for prostate cancer: current evidence and contemporary state of practice.
    Tosoian JJ; Carter HB; Lepor A; Loeb S
    Nat Rev Urol; 2016 Apr; 13(4):205-15. PubMed ID: 26954332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.
    van den Bergh RC; Ahmed HU; Bangma CH; Cooperberg MR; Villers A; Parker CC
    Eur Urol; 2014 Jun; 65(6):1023-31. PubMed ID: 24491309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Histopathological & Genetic Features to Improve Active Surveillance Selection for Low-Risk Prostate Cancer.
    Chu K; Corcoran N; Norden S; Wong LM
    Anticancer Agents Med Chem; 2018; 18(7):951-957. PubMed ID: 29141559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review.
    Schoots IG; Petrides N; Giganti F; Bokhorst LP; Rannikko A; Klotz L; Villers A; Hugosson J; Moore CM
    Eur Urol; 2015 Apr; 67(4):627-36. PubMed ID: 25511988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based approach to active surveillance of prostate cancer.
    Witherspoon L; Breau RH; Lavallée LT
    World J Urol; 2020 Mar; 38(3):555-562. PubMed ID: 30726506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.
    Tosoian JJ; Mamawala M; Patel HD; Alam R; Epstein JI; Ross AE; Carter HB
    J Urol; 2018 Apr; 199(4):954-960. PubMed ID: 29074222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOW RISK PROSTATE CANCER: ACTIVE TREATMENT OR ACTIVE SURVEILLANCE?
    Tomašković I
    Acta Clin Croat; 2015 Sep; 54(3):337-44. PubMed ID: 26666105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance for prostate cancer: a systematic review of the literature.
    Dall'Era MA; Albertsen PC; Bangma C; Carroll PR; Carter HB; Cooperberg MR; Freedland SJ; Klotz LH; Parker C; Soloway MS
    Eur Urol; 2012 Dec; 62(6):976-83. PubMed ID: 22698574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
    Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC
    J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidates for observation.
    van den Bergh RC; Murphy DG; Costello AJ
    Curr Opin Urol; 2015 May; 25(3):252-7. PubMed ID: 25692721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer.
    Goldberg H; Klaassen Z; Chandrasekar T; Fleshner N
    Curr Opin Urol; 2018 Jan; 28(1):46-54. PubMed ID: 29028765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
    Aghazadeh MA; Frankel J; Belanger M; McLaughlin T; Tortora J; Staff I; Wagner JR
    J Urol; 2018 May; 199(5):1196-1201. PubMed ID: 29288120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.
    Venderbos LD; Roobol MJ; Bangma CH; van den Bergh RC; Bokhorst LP; Nieboer D; Godtman R; Hugosson J; van der Kwast T; Steyerberg EW
    World J Urol; 2016 Feb; 34(2):253-60. PubMed ID: 26160006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up.
    Ha JY; Shin TJ; Jung W; Kim BH; Park CH; Kim CI
    Investig Clin Urol; 2017 May; 58(3):164-170. PubMed ID: 28480341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.